Monte Morin

Avandia, a controversial diabetes drug that was thought to increase patients’ risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration.

Federal regulators said Monday that the drug was no more dangerous than other diabetes medications and that it should be available to all patients without its current restrictions.

“Our actions today reflect the most current scientific knowledge about the risks and benefits of this drug,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in a statement. “Given these new results, our level of concern is considerably...

Related "Monte Morin" Articles

Avandia, a controversial diabetes drug that was thought to increase patients’ risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration.
Federal regulators said Monday that the drug...